Pharmaceuticals

Nutraceutical Industry Development Conference will be Organised during HNC 2015

SHANGHAI, March 20, 2015 /PRNewswire/ -- From June 24-26, 2015, the Nutraceutical Industry Development Conference - China Market Entry Strategy for Foreign Dietary Supplements, will be organised during HNC 2015, the leading health expo, at SNIEC inShanghai, China. As the organiser, UBM Sinoexpo ...

2015-03-20 09:00 1536

Hong Kong Authority Approves Abraxane(R) as First-Line Treatment For Late-Stage Pancreatic Cancer

HONG KONG, March 18, 2015 /PRNewswire/ -- Celgene announced today that a new treatment option for late-stage pancreatic cancer is now available for use in Hong Kong. Approved by the Department of Health, Abraxane® (paclitaxel formulated as albumin-bound nanoparticles) is indicated for use in combi...

2015-03-18 14:00 2979

Breast Cancer: Targeted Therapies Offer Novel Treatment Modalities

LONDON, March 17, 2015 /PRNewswire/ -- Despite the availability of approximately 25 drugs for the treatment of breast cancer, the unmet need in the global market is vast. To address this drawback, pharmaceutical companies have established a robust pipeline that currently has about52 drugs in dev...

2015-03-17 18:57 1065

Sirtex Reports Preliminary SIRFLOX Study Results

SYDNEY, March 17, 2015 /PRNewswire/ -- * In the first-line treatment of non-resectable metastatic colorectal cancer:  * SIRFLOX study does not show a statistically significant improvement in overall Progression-Free Survival.  * SIRFLOX study does show a statistically significant improvement ...

2015-03-17 15:28 2300

A New Therapeutic Vaccine Successfully Developed Against Rabies

BEIJING, March 16, 2015 /PRNewswire/ -- Yisheng Biopharma Co., Ltd.  ("Yisheng Biopharma"), a biopharmaceutical company focusing on the research, development, manufacturing, sales and marketing of vaccine products, announced that a new vaccine for the post exposure treatment of the rabies infecti...

2015-03-16 22:53 1715

Samsung Bioepis Submits Marketing Authorization Application For SB2, A Remicade (Infliximab) Biosimilar Candidate, To The European Medicines Agency

INCHEON, South Korea, March 13, 2015 /PRNewswire/ -- Samsung Bioepis Co., Ltd., today announced that the Marketing Authorization Application (MAA) for SB2, its Remicade (Infliximab) biosimilar candidate, has been submitted to the European Medicines Agency (EMA). This is the second biosimilar cand...

2015-03-13 20:00 2522

China's BeiGene Selects SAFC CHOZN® Platform for Commercial Drug Development

ST. LOUIS, March 11, 2015 /PRNewswire/ -- Sigma-Aldrich® Corporation (NASDAQ: SIAL) today announced that SAFC® Commercial (www.sigma-aldrich.com/safc ), its custom manufacturing services business unit, entered a commercial sales and service contract with leading...

2015-03-11 19:00 1826

Green Cross Expands Cell Therapy Business in China

YONGIN, South Korea, March 11, 2015 /PRNewswire/ -- Green Cross, a South Korean biopharmaceutical company, today announced that it had signed MOU on the 6th of March with theGuizhou provincial government of China for the investment in the cell therapy sector inChina. Under the MOU, the company ...

2015-03-11 15:56 1704

Takeda Announces Publication in The Lancet of a Post Hoc Analysis of Data from the EXAMINE Cardiovascular Safety Outcomes Trial

OSAKA, Japan, March 10, 2015 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) announced that a post hoc analysis of data from the global EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Synd...

2015-03-10 07:01 1218

DKSH Expands Asian Market for Sumitomo Dainippon Pharma

HONG KONG, March 5, 2015 /PRNewswire/ -- DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business inAsia, will provide marketing, sales and regulatory services as well as distribution and logistics for lurasidone hydrochloride (generic name, "lurasi...

2015-03-05 16:04 2237

Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan

KUALA LUMPUR, Malaysia, March 4, 2015 /PRNewswire/ -- The packaging industry plays a major role in the pharmaceutical market. It not only provides containment and drug safety but also ensures identity, convenience of handling, and proper delivery. As patent loss delivers more generics into the ma...

2015-03-04 13:18 1307

2015 Manufacturing Leadership Award Winners Announced

MOUNTAIN VIEW, Calif., March 4, 2015 /PRNewswire/ -- Frost & Sullivan's Manufacturing Leadership (ML) Council today recognized world-class manufacturing companies and individual leaders as winners of the 2015 Manufacturing Leadership Awards. ...

2015-03-04 00:42 3087

Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics

MOUNTAIN VIEW, Calif., March 3, 2015 /PRNewswire/ -- Based on its recent analysis of the enhanced drug discovery market, Frost & Sullivan recognizes Neopeutics, Inc. with the 2015 North America Frost & Sullivan Award for Technology Leadership. Neopeutics has demonstrated a remarkable ability to ...

2015-03-03 22:00 1949

Denovo Biopharma Licenses Late-Stage Neuroscience Drug From Lilly For Development As A Personalized Medicine

SAN DIEGO, March 3, 2015 /PRNewswire/ -- Denovo Biopharma, LLC, today announced that it has exclusively licensed Pomaglumetad Methionil (mGlu2/3 receptor agonist), a late-stage neuroscience drug, from Eli Lilly and Company (NYSE:  LLY). Denovo gains all rights to develop, manufacture and commerci...

2015-03-03 21:00 1611

Mundipharma Demonstrates How You Can Keep Yourself And Your Loved Ones Protected With BETADINE In Relieving Influenza Symptoms

HONG KONG, March 3, 2015 /PRNewswire/ -- The current outbreak of Influenza in Hong Kong has claimed 164 lives this year1. Among the reported cases, 232 were A (H3N2), six were B and nine were A pending subtype1. In addition to a growing strain on medical infrastructure and supplies, the prevalent...

2015-03-03 20:19 1988

Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments

LONDON, March 3, 2015 /PRNewswire/ -- Although lung cancer is the third most prevalent cancer type in the world, there are only 18 drugs in the market for its treatment. Further, popular drugs such asAlmita and Avastin are nearing theirpatent expiry in 2015 and 2017 respectively. As such, the ...

2015-03-03 19:38 1189

15th Anniversary, Be Part of Chinese Pharma Dream

SHANGHAI, March 3, 2015 /PRNewswire/ -- - CPhI and P-MEC China 2015 - 24 - 26 June 2015, SNIEC, Shanghai, China - The 15th CPhI China, together with the 10th P-MEC China, will be held at Shanghai New International Expo Center, on24th June, 2015. CPhI & P-MEC China originated from CPhI Worldwid...

2015-03-03 15:10 1250

Novogen to Present at AusBiotech "Broker Meets Biotech" Event

SYDNEY, March 3, 2015 /PRNewswire/ -- Novogen Ltd (ASX: 'NRT'; Nasdaq: 'NVGN'), an Australian-US drug discovery company focused on the clinical development of drugs targeting two novel drug targets pertinent to a range of therapeutic indications, announced today thatGraham Kelly, PhD, CEO and Exe...

2015-03-03 11:02 1493

RM Group Enters into the PRC Market

HONG KONG, Feb. 27, 2015 /PRNewswire/ -- RM Group Holdings Limited ("RM Group" or the "Company") (HKEx stock code: 8185) and its subsidiaries (the "Group") announced that it entered into a distribution agreement with Shanghai Dong Jiao Industrial Company Limited in respect of the distribution and...

2015-02-27 18:48 2479

Omnicell, Inc. Signs Agreement to Acquire Germany-based Pharmacy Automation Provider, MACH4 Pharma Systems

MOUNTAIN VIEW, Calif., Feb. 27, 2015 /PRNewswire/ -- Omnicell, Inc . (OMCL), a leading provider of medication and supply management solutions to healthcare systems and pharmacies, today announced that it has signed an agreement to purchase MACH4 Pharma Systems, based in ...

2015-02-27 11:25 2296
1 ... 949596979899100 ... 105